Floatz logo

59 assets in Rhabdomyosarcoma

Therapeutic assets addressing Rhabdomyosarcoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
ln-144
Rhabdomyosarcoma
Iovance Biotherapeutics, Inc.P1C (39)
Mesna
Rhabdomyosarcoma
St. Jude Children's Research HospitalP1C (39)
Pembrolizumab
Rhabdomyosarcoma
Seattle Children's HospitalP1C (39)
Sc-Car.Gpc3Xil15.21 Car T Cells
Rhabdomyosarcoma
Seattle Children's HospitalP1C (39)
Second Generation 4-1Bbζ B7H3-Egfrt-Dhfr
Rhabdomyosarcoma
Seattle Children's HospitalP1C (39)
Second Generation 4-1Bbζ Egfr806-Egfrt
Rhabdomyosarcoma
Seattle Children's HospitalP1C (39)
Second Generation 4-1Bbζ Egfr806-Egfrt And A Second Generation 4 1Bbζ Cd19-Her2Tg
Rhabdomyosarcoma
Seattle Children's HospitalP1C (39)
Val-413
Rhabdomyosarcoma
Valent Technologies, LLCP1C (39)
Vorinostat
Rhabdomyosarcoma
New York Medical CollegeP1C (39)
Showing 51 to 59 of 59 assets
PreviousPage 2 of 2Next